Plaque Psoriasis Overview

Save information for later
Sign Up

Learn About Plaque Psoriasis

What is the definition of Plaque Psoriasis?
Plaque psoriasis is the most common form of psoriasis. Psoriasis is an autoimmune skin disorder that affects the growth rate of skin cells. Plaque psoriasis causes raised, reddened dry skin patches with silvery scales that appear on the scalp, elbows, knees, trunk and back.
What are the symptoms of Plaque Psoriasis?
Plaque psoriasis appears in cycles, with periods of remission followed by flare-ups that can last from weeks to months. Symptoms of plaque psoriasis during flare-ups can include reddened, dry skin patches covered in thick silvery scales, usually on the elbows, arms, knees, abdomen, and back, that may cause itching, burning, or bleeding. The sizes of the psoriasis plaques can range from small spots to covering large areas of the body. Nearly half of patients with psoriasis also have abnormal, thickened nails that are pitted or ridged. Psoriasis can also affect the mouth or genitals.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Plaque Psoriasis?
There is currently no cure for plaque psoriasis. Treatments for plaque psoriasis include topical therapy, such as corticosteroids, Vitamin D analogues, retinoids, calcineurin inhibitors, salicylic acid, coal tar, Goeckerman therapy, and anthralin; light therapy; other oral or injected medications; biologics; and alternative therapies.
Who are the top Plaque Psoriasis Local Doctors?
Elite in Plaque Psoriasis
Dr. Jerry Bagel
Dermatology
Elite in Plaque Psoriasis
Dr. Jerry Bagel
Dermatology

Schweiger Dermatology Group - East Windsor

59 One Mile Road, Suite G59, 
East Windsor, NJ 
609-443-4500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jerry Bagel is a Dermatologist in East Windsor, New Jersey. Dr. Bagel is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Plaque Psoriasis, Psoriasis, Atopic Dermatitis, and Giant Congenital Melanocytic Nevus. Dr. Bagel is currently accepting new patients.

Bruce E. Strober
Elite in Plaque Psoriasis
Dr. Bruce E. Strober
Dermatology
Elite in Plaque Psoriasis
Dr. Bruce E. Strober
Dermatology

Central Connecticut Dermatology PLLC

1 Willowbrook Rd, Suite 2, 
Cromwell, CT 
860-322-2222
Languages Spoken:
English
See accepted insurances

Bruce Strober is a Dermatologist in Cromwell, Connecticut. Dr. Strober is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Psoriasis, Plaque Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).

 
 
 
 
Learn about our expert tiers
Learn More
Andrew Blauvelt
Elite in Plaque Psoriasis
Dr. Andrew Blauvelt
Dermatology
Elite in Plaque Psoriasis
Dr. Andrew Blauvelt
Dermatology
9495 Sw Locust Street, Suite A, 
Portland, OR 
503-445-2200
Languages Spoken:
English
See accepted insurances

Andrew Blauvelt is a Dermatologist in Portland, Oregon. Dr. Blauvelt is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Plaque Psoriasis, Psoriasis, Atopic Dermatitis, and Actinic Keratosis.

View All Doctors
What are the latest Plaque Psoriasis Clinical Trials?
A Multicenter, Prospective, Study to Evaluate the Impact of Modifying the Validated Psoriasis Epidemiology Screening Tool (PEST) on the Potential Diagnosis of Psoriatic Arthritis in Adult Patients With Moderate-to-severe Plaque Psoriasis in Canada (ScreenX)
A Multicenter, Prospective, Study to Evaluate the Impact of Modifying the Validated Psoriasis Epidemiology Screening Tool (PEST) on the Potential Diagnosis of Psoriatic Arthritis in Adult Patients With Moderate-to-severe Plaque Psoriasis in Canada (ScreenX)
Enrollment Status: Recruiting
Publish Date: October 14, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable

Summary: The purpose of this study is to assess the impact of adding two questions and pictures to the validated PEST on the potential diagnosis of PsA in participants with moderate-to-severe plaque PsO in Canada.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
Who is this study for: Patients with Plaque Psoriasis
Enrollment Status: Recruiting
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Tapinarof Cream, 1%
Study Phase: Phase 3

Summary: This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cream, 1% in pediatric subjects with plaque psoriasis.

View All Clinical Trials